These findings suggest that VEGF-C-mediated lymphangiogenesis contributes significantly to hypertension-induced cardiac remodeling, making it a potential therapeutic target for hypertension-related cardiac diseases [44]. This evidence concerns the gene VEGFC and Hypertension.